MARAVAI LIFESCIENCES HLDGS-A (MRVI)

Company Profile

Maravai Lifesciences Holdings, Inc. is a life sciences company. The company is headquartered in San Diego, California and currently employs 580 full-time employees. The company went IPO on 2020-11-20. The firm provides products that enable the development of drug therapies, diagnostics and vaccines and to support research on human diseases. Its companies provide products and services in the fields of nucleic acid synthesis and biologics safety testing to various biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. The firm operates through two segments. Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acid products to support the needs of customer research, therapeutic and vaccine programs. The segment also provides research products for labeling and detecting proteins in cells and tissue samples. Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities.

Company Info

MARAVAI LIFESCIENCES HLDGS-A

10770 Wateridge Circle Suite 200, Suite 200

San Diego CALIFORNIA 92121

P: 18585460004

CEO: Carl Hull

Employees: 580

Website: https://www.maravai.com/